Page 353 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Giant Cell Arteritis 327

[25] Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections. Curr. Opin.
Rheumatol, 2006; 18:39-47.

[26] Helweg-Larsen J, Tarp B, Obel N, et al. No evidence of parvovirus B19, Chlamydia
pneumoniae or human herpes virus infection in temporal artery biopsies in patients with
giant cell arteritis. Rheumatology, 2002; 41:445-449.

[27] Pipitone N, Bioardi L, Bajocchi G, et al. Long term outcome of giant cell arteritis.
Clinical and Experimental Rheumatology, 2006; 24S65-S70.

[28] Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia Rheumatica and Giant Cell
Arteritis. N. Engl. J. Med., 2002; 347:261-271.

[29] Lie JT. Illustrated criteria for histopathologic classification of selected vasculitis
syndromes. Arthritis Rheum. 1990; 33:1074-1087.

[30] Restuccia G, Cavazza A, Boiardi L, et al. Small-vessel vasculitis surrounding an
uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery:
two subsets of giant cell arteritis. Arthritis Rheum. 2012; 64:549–556.

[31] Cox M, Gilks B. Healed or quiescent temporal arteritis versus senescent changes in
temporal artery biopsy specimens. Pathology, 2001; 33:163–166.

[32] Makkuni D, Bharadwaj A, Wolfe K, et al. Is intimal hyperplasia a marker of neuro-
ophthalmic complications of giant cell arteritis? Rheumatology 2008; 47:488–490.

[33] Lie JT. When is arteritis of the temporal arteries not temporal arteritis. Journal of
Rheumatology, 1994; 21:186-189.

[34] Nishino H, DeRemee RA, Rubino FA, et al. Wegener?s granulomatosis associated with
vasculitis of the temporal artery: report of five cases. Mayo Clin. Proc., 1993; 68:115-
121.

[35] Sieber SC, Cuello B, Gelfman NA, et al. Pulmonary capillaritis and glomerulonephritis
in an antineutrophil cytoplasmic antibody-positive patient with prior granulomatous
aortitis. Arch. Pathol. Lab. Med., 1990; 114:1223-1226.

[36] Proctor PR, Lotz BP. Sarcoidosis and giant cell arteritis [letter]. Clin. Exp. Dermatol.,
1992; 17:143-144.

[37] Lesser RS, Aledort D, Lie JT. Non giant cell arteritis of the temporal artery presenting
as the polymyalgia rheumatica-temporal arteritis syndrome. J. Rheumatol., 1995;
22:2177-2182.

[38] Weyand CM, Goronzy JJ. Polymyalgia Rheumatica and Giant Cell Arteritis. In:
Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology 5th
Ed. Maryland Heights:Mosby; 2010:1535-1545.

[39] Pryshchep O, Ma-Krupa W, Younge BR, et al: Vessel-specific Toll-like receptor
profiles in human medium and large arteries. Circulation, 2008; 118:1276-1284.

[40] Han JW, Shimada K, Ma-Krupa W, et al. Vessel Wall-Embedded Dendritic Cells
Induce T-Cell Autoreactivity and Initiate Vascular Inflammation. Circ. Res., 2008;
102:546-553.

[41] Deng J, Ma-Krupa W, Gewirtz AT, et al: Toll-like receptors 4 and 5 induce distinct
types of vasculitis. Circ. Res., 2009; 104:488-495.

[42] Weyand CM, Tetzlaff N, Bjornsson J, et al: Disease patterns and tissue cytokine
profiles in giant cell arteritis. Arthritis Rheum., 1997; 40:19-26.

[43] Deng J, Younge B, Brian R, et al. Th17 and Th1-cell responses in giant cell arteritis.
Circulation, 2010; 121:906-915.

Complimentary Contributor Copy